Daniela Zaffaroni

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

Journal: Tumori
Published: September 11, 2023

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Journal: Nature genetics
Published: May 30, 2016

Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.

Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.

Journal: European journal of internal medicine
Published: February 04, 2016

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Journal: JAMA
Published: April 08, 2015

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Journal: Gynecologic oncology
Published: March 09, 2015

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: October 23, 2014

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

Journal: Breast cancer research : BCR
Published: September 17, 2014

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

Journal: Breast cancer research : BCR
Published: January 01, 2014

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

Journal: PLoS genetics
Published: October 23, 2013

Characterization of an Italian founder mutation in the RING-finger domain of BRCA1.

Characterization of an Italian founder mutation in the RING-finger domain of BRCA1.

Journal: PloS one
Published: August 28, 2013

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

Journal: Nature genetics
Published: July 06, 2012

The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians.

The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians.

Journal: Breast cancer research and treatment
Published: February 24, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026